Literature DB >> 36205781

The beta subunit of AMP-activated protein kinase is critical for cell cycle progression and parasite development in Toxoplasma gondii.

Jichao Yang1, Xuke Yang1, Anqi Liu1, Yaqiong Li1, Zhipeng Niu1, Congcong Lyu1, Xiaohan Liang1, Ningbo Xia1, Jianmin Cui1, Mingjun Li1, Ping Wu2, Chao Peng2, Bang Shen3,4,5.   

Abstract

Toxoplasma gondii is a widespread eukaryotic pathogen that causes life-threatening diseases in humans and diverse animals. It has a complex life cycle with multiple developmental stages, which are timely adjusted according to growth conditions. But the regulatory mechanisms are largely unknown. Here we show that the AMP-activated protein kinase (AMPK), a key regulator of energy homeostasis in eukaryotes, plays crucial roles in controlling the cell cycle progression and bradyzoite development in Toxoplasma. Deleting the β regulatory subunit of AMPK in the type II strain ME49 caused massive DNA damage and increased spontaneous conversion to bradyzoites (parasites at chronic infection stage), leading to severe growth arrest and reduced virulence of the parasites. Under alkaline stress, all Δampkβ mutants converted to a bradyzoite-like state but the cell division pattern was significantly impaired, resulting in compromised parasite viability. Moreover, we found that phosphorylation of the catalytic subunit AMPKα was greatly increased in alkaline stressed parasites, whereas AMPKβ deletion mutants failed to do so. Phosphoproteomics found that many proteins with predicted roles in cell cycle and cell division regulation were differentially phosphorylated after AMPKβ deletion, under both normal and alkaline stress conditions. Together, these results suggest that the parasite AMPK has critical roles in safeguarding cell cycle progression, and guiding the proper exist of the cell cycle to form mature bradyzoites when the parasites are stressed. Consistent with this model, growth of parasites was not significantly altered when AMPKβ was deleted in a strain that was naturally reluctant to bradyzoite development.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  AMPK; Bradyzoite development; Cell cycle; Phosphorylation; Toxoplasma gondii

Mesh:

Substances:

Year:  2022        PMID: 36205781     DOI: 10.1007/s00018-022-04556-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.207


  35 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

Review 2.  Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

Authors:  J P Dubey; D S Lindsay; C A Speer
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 3.  Toxoplasma gondii dissemination: a parasite's journey through the infected host.

Authors:  K S Harker; N Ueno; M B Lodoen
Journal:  Parasite Immunol       Date:  2015-03       Impact factor: 2.280

4.  A cell culture system for study of the development of Toxoplasma gondii bradyzoites.

Authors:  L M Weiss; D Laplace; P M Takvorian; H B Tanowitz; A Cali; M Wittner
Journal:  J Eukaryot Microbiol       Date:  1995 Mar-Apr       Impact factor: 3.346

Review 5.  Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention.

Authors:  Stacey A Elmore; Jeffrey L Jones; Patricia A Conrad; Sharon Patton; David S Lindsay; J P Dubey
Journal:  Trends Parasitol       Date:  2010-03-02

Review 6.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

Review 7.  Mechanisms of Toxoplasma gondii persistence and latency.

Authors:  William J Sullivan; Victoria Jeffers
Journal:  FEMS Microbiol Rev       Date:  2011-10-04       Impact factor: 16.408

Review 8.  Advances in the life cycle of Toxoplasma gondii.

Authors:  J P Dubey
Journal:  Int J Parasitol       Date:  1998-07       Impact factor: 3.981

9.  The Toxoplasma gondii oocyst from cat feces.

Authors:  J P Dubey; N L Miller; J K Frenkel
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Transcriptional repression by ApiAP2 factors is central to chronic toxoplasmosis.

Authors:  Joshua B Radke; Danielle Worth; David Hong; Sherri Huang; William J Sullivan; Emma H Wilson; Michael W White
Journal:  PLoS Pathog       Date:  2018-05-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.